# FDA 483 - Rabi Hanna, M.D. - October 07, 2024

Source: https://www.globalkeysolutions.net/records/483/rabi-hanna-md/c2863b71-0510-4b23-bd41-0e8cb6029aca

> FDA 483 for Rabi Hanna, M.D. on October 07, 2024. Product: drugs. Access full analysis and detailed observations.

---

## Details

- Record Type: 483
- Company Name: Rabi Hanna, M.D.
- Inspection Date: 2024-10-07
- Product Type: drugs
- Office Name: Cincinnati District Office
- Summary: An FDA inspection of Clinical Investigator Rabi Hanna, MD at Cleveland Clinic in Cleveland, OH, identified two significant observations related to clinical trial conduct. The firm failed to promptly report a serious adverse event to the study sponsor and did not conduct the investigation in accordance with the approved protocol, specifically regarding the collection of required lab samples for a subject.

## Related Officers

- [Brittany M. Kershaw](https://www.globalkeysolutions.net/people/brittany-m-kershaw/b0e79b65-9d6f-4f5d-8a60-1a32df8c1b61)

Company: https://www.globalkeysolutions.net/companies/rabi-hanna-md/2035d12e-d80c-4825-85b4-330b2b6d10ca

Office: https://www.globalkeysolutions.net/offices/cincinnati-district-office/b67a0c35-82e3-4176-9039-988378f65c22